Inventor · disambiguated record
Lijs Beke
Also filed as: BEKE LIJS
8 granted patents·4 pending applications·7 citations·filing 2009–2024
77Inventor score
Top patents by PatentIndex Score
12 records- 0191US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0283US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0377US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0477US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0574US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 0668US11999993B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 4, 2024·0 cites·8 claims
- 0768US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 0866US2025066510A1Gucy2c antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0960US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 1057US11279970B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 22, 2022·0 cites·8 claims
- 1155US2009203010A1MSMB-gene based diagnosis, staging and prognosis of prostate cancerUNIV LEUVEN KATH·Filed 2009·Application pending·0 cites
- 1244US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Lijs Beke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →